CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GEN - Genetic Engineering & Biotech News
Original article

Pioneering Study of Alpha-Gal Syndrome Launched at Martha’s Vineyard Hospital

Trial StartNeutral
AI Analysis

Summary

Martha's Vineyard Hospital launched a two-year observational study tracking up to 300 residents to investigate the development and etiology of alpha-gal syndrome following lone star tick exposure.

Clinical Trial Data

Patients

300

Importance:2/10
Sentiment:
0.00
alpha-gal syndromelone star tickepidemiology studyMartha's Vineyard
Related Companies

Read the original article

Published by GEN - Genetic Engineering & Biotech News on August 25, 2026 1:00 PM

Read Original